Current Report Filing (8-k)
March 23 2018 - 3:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 23, 2018
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37550
|
|
47-4725208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(IRS Employer
Identification No.)
|
1573 Mallory Lane
Brentwood, Tennessee 37027
(Address of principal executive offices)
|
Registrants Telephone Number, Including Area Code: (615)
221-1400
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of
this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On March 23, 2018, Quorum Health Corporation, a Delaware corporation (the Company) announced that William M. Gracey,
previously the Chair of the Companys Board of Directors (Board) and member of the Companys Compensation and Governance and Nominating Committees, is resigning effective March 23, 2018 due to other professional and personal
commitments, and the Board has elected Terry Allison Rappuhn as the new Chair of the Board. Mr. Graceys resignation was not the result of any disagreement with the Company with respect to its financial and auditing policies, operations or
practices.
Item 7.01
|
Regulation FD Disclosure.
|
On March 23, 2018, the Company issued a press release
(the Press Release) announcing the foregoing changes. A copy of the Press Release is attached as Exhibit 99.1 and is incorporated herein by reference.
Pursuant to the rules and regulations of the SEC, the information in this Item 7.01 disclosure, including Exhibit 99.1 and information set
forth therein, is deemed to have been furnished and shall not be deemed to be filed under the Securities Exchange Act of 1934, as amended.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
|
|
QUORUM HEALTH CORPORATION
(registrant)
|
|
|
By:
|
|
/s/ Michael J. Culotta
|
|
|
Michael J. Culotta
Executive Vice
President
and Chief Financial Officer
(principal financial
officer
and principal accounting officer)
|
Date: March 23, 2018
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Apr 2024 to May 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Quorum Health Corporation (New York Stock Exchange): 0 recent articles
More Quorum Health Corp News Articles